Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy

Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy

Bibliographic Details
Main Authors:	Sharmistha Mitra, Baozhi Chen, Peixiang Wang, Erin E. Chown, Mathew Dear, Dikran R. Guisso, Ummay Mariam, Jun Wu, Emrah Gumusgoz, Berge A. Minassian
Format:	Article
Language:	English
Published:	The Company of Biologists 2023-01-01
Series:	Disease Models & Mechanisms
Subjects:	polyglucosan lafora body myoclonus
Online Access:	http://dmm.biologists.org/content/16/1/dmm049802

Similar Items

Deciphering the Polyglucosan Accumulation Present in Lafora Disease Using an Astrocytic Cellular Model
by: Mireia Moreno-Estellés, et al.
Published: (2023-03-01)

Lafora Disease and Alpha-Synucleinopathy in Two Adult Free-Ranging Moose (<i>Alces alces</i>) Presenting with Signs of Blindness and Circling
by: Madhu Ravi, et al.
Published: (2022-06-01)

Abnormal glycogen chain length pattern, not hyperphosphorylation, is critical in Lafora disease
by: Felix Nitschke, et al.
Published: (2017-07-01)

Alleviation of a polyglucosan storage disorder by enhancement of autophagic glycogen catabolism
by: Or Kakhlon, et al.
Published: (2021-10-01)

Retinal Phenotyping of a Murine Model of Lafora Disease
by: Ajoy Vincent, et al.
Published: (2023-03-01)

Role of Astrocytes in the Pathophysiology of Lafora Disease and Other Glycogen Storage Disorders
by: Jordi Duran
Published: (2023-02-01)

Two Cases of Lafora Disease Diagnosed By Genetical Tests
by: Aylin BICAN DEMIR, et al.
Published: (2021-12-01)

Two Siblings Diagnosed as Lafora Disease
by: Yasemin Biçer Gömceli, et al.
Published: (2010-03-01)

Two Siblings Diagnosed as Lafora Disease
by: Yasemin Biçer Gömceli, et al.
Published: (2010-03-01)

P-Rex1 is a novel substrate of the E3 ubiquitin ligase Malin associated with Lafora disease
by: L. Kumarasinghe, et al.
Published: (2023-02-01)

Epileptic myoclonus
by: M. B. Mironov, et al.
Published: (2020-09-01)

Lafora Disease: A Case Report
by: Ebru APAYDIN DOĞAN, et al.
Published: (2016-04-01)

A Case of Lafora Disease Diagnosed by Axillary Skin Biopsy
by: Elife KIMILOĞLU, et al.
Published: (2021-09-01)

Lafora Disease in a Teenage Girl with Epilepsy
by: Bhushan Warpe, et al.
Published: (2024-02-01)

Lafora Disease: A Case Report of Progressive Myoclonic Epilepsy
by: Sahar Delavari, et al.
Published: (2023-01-01)

A case of primary spinal myoclonus: clinical presentation and possible mechanisms involved
by: Cynthia Resende Campos, et al.
Published: (2003-03-01)

Lafora Disease: A Case Report and Evolving Treatment Advancements
by: Carola Rita Ferrari Aggradi, et al.
Published: (2023-12-01)

TNF and IL6/Jak2 signaling pathways are the main contributors of the glia-derived neuroinflammation present in Lafora disease, a fatal form of progressive myoclonus epilepsy
by: Teresa Rubio, et al.
Published: (2023-01-01)

Glial Contributions to Lafora Disease: A Systematic Review
by: Stefania Della Vecchia, et al.
Published: (2022-12-01)

Epilepsia mioclónica progresiva tipo Lafora y los casos diagnosticados en Costa Rica
by: Virginia Solís
Published: (2004-09-01)

Spinal Myoclonus Responding to Continuous Intrathecal Morphine Pump
by: Jung-Eun Ahn, et al.
Published: (2017-09-01)

Trehalose Treatment in Zebrafish Model of Lafora Disease
by: Stefania Della Vecchia, et al.
Published: (2022-06-01)

Enfermedad de Lafora y efecto fundador en una pequeña localidad neotropical
by: María Virginia Solís
Published: (2000-06-01)

MRI characteristics due to gene mutations in a Chinese pedigree with Lafora disease
by: Yueqian Sun, et al.
Published: (2023-10-01)

Pathomorphogenesis of Glycogen-Ground Glass Hepatocytic Inclusions (Polyglucosan Bodies) in Children after Liver Transplantation
by: Francesco Callea, et al.
Published: (2022-09-01)

Lafora Disease: A Ubiquitination-Related Pathology
by: Maria Adelaida García-Gimeno, et al.
Published: (2018-07-01)

Progressive Myoclonus Epilepsy: A Scoping Review of Diagnostic, Phenotypic and Therapeutic Advances
by: Vincent Zimmern, et al.
Published: (2024-01-01)

Diagnosis and treatment of functional myoclonus
by: HUANG Qing, et al.
Published: (2023-11-01)

Structural and Functional Brain Abnormalities in Mouse Models of Lafora Disease
by: Daniel F. Burgos, et al.
Published: (2020-10-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

Action Myoclonus and Renal Parenchymal Disease: A Case Report
by: Kezban ASLAN, et al.
Published: (2016-08-01)

Electrophysiologic Assessments of Involuntary Movements: Tremor and Myoclonus
by: Hyun-Dong Park, et al.
Published: (2009-05-01)

Beneficial Effects of Metformin on the Central Nervous System, with a Focus on Epilepsy and Lafora Disease
by: Pascual Sanz, et al.
Published: (2021-05-01)

Electro-clinical features and management of the late stage of Lafora disease
by: Giuseppe d'Orsi, et al.
Published: (2022-10-01)

Negative myoclonus as a manifestation of cefepime neurotoxicity
by: Daichi Umemoto, et al.
Published: (2024-01-01)

Myoclonus-Ataxia Syndrome Associated with COVID-19
by: Kuldeep Shetty, et al.
Published: (2021-05-01)

Lafora Disease: Molecular Etiology
by: S. Hande ÇAĞLAYAN
Published: (2018-04-01)

Transient Palatal Myoclonus Due to Opercular Ischemic Lesion
by: Levent Öcek, et al.
Published: (2023-09-01)

Myoclonus: Differential diagnosis and current management
by: Antonella Riva, et al.
Published: (2024-04-01)

Functional myoclonus: one case report
by: WANG Jin⁃tao, et al.
Published: (2023-11-01)